Clinical Research Directory
Browse clinical research sites, groups, and studies.
LTFU Study of Subjects With Cervical SCI Who Received AST-OPC1
Sponsor: Lineage Cell Therapeutics, Inc.
Summary
This is a LTFU study for cervical SCI subjects that were administered AST-OPC1 cells in the main study AST-OPC1-01.
Official title: A Long-term Follow-up Study of Subjects With Cervical Spinal Cord Injuries Who Received AST-OPC1 in Protocol AST-OPC1-01
Key Details
Gender
All
Age Range
18 Years - 69 Years
Study Type
OBSERVATIONAL
Enrollment
25
Start Date
2018-06-13
Completion Date
2033-01-14
Last Updated
2024-08-21
Healthy Volunteers
No
Conditions
Interventions
Magnetic Resonance Imaging (MRI)
Observational study; annual MRI for first 5 years only to monitor changes in the injection site
Locations (6)
University of Southern California
Los Angeles, California, United States
Stanford University
Palo Alto, California, United States
Shepherd Center
Atlanta, Georgia, United States
RUSH University Medical Center
Chicago, Illinois, United States
Thomas Jefferson University
Philadelphia, Pennsylvania, United States
Medical College of Wisconsin
Milwaukee, Wisconsin, United States